Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
---|---|---|---|
6/30/2025 | -15.74% | $ 94.77M | $ 14.91M |
3/31/2025 | -19.38% | $ 76.96M | $ 14.91M |
12/31/2024 | -14.09% | $ 108.65M | $ 15.31M |
9/30/2024 | 0% | $ 289.27M | $ 0 |
6/30/2024 | 0% | $ 317.84M | $ 0 |
3/31/2024 | 0% | $ 423.43M | $ 0 |
12/31/2023 | 0% | $ 342.36M | $ 0 |
9/30/2023 | 0.05% | $ 206.12M | $ -94K |
6/30/2023 | -28.91% | $ 100.42M | $ 29.03M |
3/31/2023 | -24.71% | $ 117.5M | $ 29.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield
Debt Paydown Yield for TSCAN THERAPEUTICS INC is calculated as follows: (-1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 0 ]
(=) Debt Paydown Yield [ 0% ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.28K |
---|---|
min | -11.36% |
max | 11.41% |
average | -0.08% |
median | 0% |
std | 3.81% |